Trial record 1 of 1 for:    NCT01747486.
Previous Study | Return to List | Next Study

CD19 Redirected Autologous T Cells

This study is currently recruiting participants. (see Contacts and Locations)
Verified December 2012 by Abramson Cancer Center of the University of Pennsylvania
Sponsor:
Information provided by (Responsible Party):
Abramson Cancer Center of the University of Pennsylvania
ClinicalTrials.gov Identifier:
NCT01747486
First received: December 10, 2012
Last updated: December 11, 2012
Last verified: December 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2015
  Estimated Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)